(Q38995864)

8 September 2017

title

Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). (English)

1 reference

8 September 2017

Yezi Zhu

1

1 reference

8 September 2017

Chengfei Liu

2

1 reference

8 September 2017

Yuanyuan Cui

3

1 reference

8 September 2017

Nagalakshmi Nadiminty

4

1 reference

8 September 2017

Wei Lou

5

1 reference

8 September 2017

Allen C Gao

6

1 reference

8 September 2017

publication date

12 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

74

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

1086-1094

1 reference

Neuroendocrine differentiation in the progression of prostate cancer

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Molecular mechanisms of castration-resistant prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

RhoGDIα suppresses growth and survival of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

REST in good times and bad: roles in tumor suppressor and oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

REST: an oncogene or a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

REST-VP16 activates multiple neuronal differentiation genes in human NT2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

A genetic screen for candidate tumor suppressors identifies REST

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22819

21 January 2018

Identifiers

DOI

10.1002/PROS.22819

1 reference

8 September 2017

1 reference